Smith & Nephew moves BlueSky facility to Florida:
This article was originally published in Clinica
Executive Summary
Smith & Nephew has initiated the integration of BlueSky Medical, the negative pressure wound therapy (NPWT) company it bought in May (see Clinica No 1256, p 12), into its advanced wound management business. S&N will carry out a phased withdrawal from BlueSky's facility in California over the next six months, with the latter's operations moved to S&N's US headquarters in Largo, Florida. The $1.2bn NPWT worldwide market is said to be the fastest growing segment in wound care.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.